Insider
Moderna, Inc.MRNA

Moderna President Stephen Hoge executed planned stock transactions

Moderna President Stephen Hoge executed stock transactions between October 14 and October 15, 2026. During this period, he exercised options to acquire 152,905 shares and sold 78,369 shares on the market.

Verified against 3 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
a very tall building next to a very tall building
Photo by Georgi Kalaydzhiev on Unsplash
78,369
Shares sold
$17,013,537.68
Value of shares sold
152,905
Shares acquired

Key points

  • In mid-October 2026, Moderna President Stephen Hoge conducted several company stock transactions.
  • All cited transactions were conducted under a 10b5-1 plan, a preset selling schedule executives set up to avoid suspicions of insider trading.

Company president's transactions

In mid-October 2026, Moderna President Stephen Hoge conducted several company stock transactions. Over two days, he acquired 152,905 shares through option exercises and sold 78,369 shares on the open market. The total value of the shares sold was $17,013,537.68.

Why this should not be considered a signal

All cited transactions were conducted under a 10b5-1 plan, a preset selling schedule executives set up to avoid suspicions of insider trading. This plan was adopted on June 15, 2026. Therefore, such sales are automatic and planned in advance, rather than indicating a change in the executive's outlook on business prospects.

Original sources

  1. 144 filing, October 14, 2026October 14, 2026SHA-256 of our archived copy d75985b7c71e…
  2. 144 filing, October 15, 2026October 15, 2026SHA-256 of our archived copy 82a333eeb477…
  3. 4 filing, October 16, 2026October 16, 2026SHA-256 of our archived copy 89ca2c392c31…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards